The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Top Cited Papers
- 18 December 2020
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 69 (50), 1922-1924
- https://doi.org/10.15585/mmwr.mm6950e2
Abstract
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 12, 2020, for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years.Keywords
This publication has 2 references indexed in Scilit:
- The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020Morbidity and Mortality Weekly Report (MMWR), 2021
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020Morbidity and Mortality Weekly Report (MMWR), 2020